CD44 and cancer: The ability to regulate the CD44/HA interaction through therapeutic manipulation of the redox state of the Cys77-Cys97 disulfide bond could provide a handle towards limiting leukocyte migration to sites of inflammation in autoimmune disease and the migration of metastatic cancer cells thought the lymphatic system.